Status:
COMPLETED
Vertebral Fracture and Osteonecrosis Associated With High-dose Glucocorticoid
Lead Sponsor:
Saitama Medical University
Conditions:
Vertebral Fracture
Osteonecrosis
Eligibility:
All Genders
20+ years
Brief Summary
Osteoporotic vertebral fracture (VF) and osteonecrosis of the femoral head (OFH) are major concerns in patients with systemic rheumatic diseases treated with high-dose glucocorticoids (GCs). The inves...
Detailed Description
Patients with rheumatic diseases receiving GCs (≧0.5 mg/kg/day for prednisolone equivalent) within the past 2 months were enrolled in this study, and treated with 200 mg/day of etidronate cyclically. ...
Eligibility Criteria
Inclusion
- Patients admitted to our hospital for the treatment of active systemic rheumatic diseases taking at least 0.5 mg/kg/day for PSL equivalent between January 2001 and June 2003 were eligible for this prospective study
Exclusion
- Patients who were not appropriate for this study
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00679978
Start Date
January 1 2001
End Date
October 1 2007
Last Update
September 18 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.